Pathway Genomics: Clinical Trials

5 trials sponsored by Pathway Genomics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Pathway Genomics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cancer DNA Screening Pilot Study (CANDACE)
Circulating tumor DNA assay - Circulating Tumor Cells
Not applicableCompletedBritish Columbia Cancer Agency15142016-09-192020-08-24
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
Cancer of the Lung, Lung Cancer
TerminatedPathway Genomics392016-06-012017-08-21
ctDNA in Patients With Thyroid Nodules
Thyroid Cancer, Thyroid Nodules
TerminatedPathway Genomics662016-05-012017-08-21
Plasma ctDNA in Patients Undergoing Diagnostic Colonoscopy
Colon Cancer, Colon Adenomas
CompletedPathway Genomics2062016-01-012017-08-21
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
ctDNA Analysis for the Detection of Genetic Mutations - Mutation, Neoplasms
CompletedPathway Genomics11062015-11-012018-04-06

Conditions studied

Adenocarcinoma of Lung (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colonic Neoplasms (1)  ·  Colonic Polyps (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplastic Cells, Circulating (1)  ·  Small Cell Lung Carcinoma (1)  ·  Thyroid Neoplasms (1)  ·  Thyroid Nodule (1)  ·  Thyroiditis (1)

Countries

United States (4)  ·  Canada (1)

Top investigators

Anja Kammesheidt, PhD (2)  ·  Alan M Nichol, MD (1)  ·  Glenn Braunstein, MD (1)  ·  Glenn D Braunstein, MD (1)  ·  Glenn D. Braunstein, M.D. (1)  ·  Robert J. McKenna, M.D. (1)